Hims & Hers Health is trading 4.07% down at €25.90 after the August 6, 2026 session, with no confirmed company-specific catalyst identified.
- The company announced a new AI-native Hers app for weight-loss members; the update appears operationally positive rather than bearish.
- Broader market weakness was limited, leaving the decline unexplained.
- The move may reflect profit-taking or ongoing concerns around regulatory scrutiny.